Characteristics of trabeculated myocardium burden in young and apparently healthy adults

American Journal of Cardiology

Volumn 114, Issue 7, 2014, Pages 1094-1099

  Tizón Marcos, Helena ^a,b   De La Paz Ricapito, Maria ^a,b   Pibarot, Philippe ^a,b   Bertrand, Olivier ^a,b   Bibeau, Karine ^a,b   Le Ven, Florent ^a,b   Sinha, Swapnil ^c,d   Engert, James ^e   Bédard, Elisabeth ^a,b   Pasian, Sergio ^a,b   Deschepper, Christian ^c,d   Larose, Eric ^a,b  

^a LAVAL UNIVERSITY   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

^c CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

^d UNIVERSITÉ DE MONTRÉAL   (Canada)

^e MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BRAIN NATRIURETIC PEPTIDE; PEPTIDE FRAGMENT; PRO BRAIN NATRIURETIC PEPTIDE (1 76); PRO-BRAIN NATRIURETIC PEPTIDE (1-76); PROTEIN PRECURSOR;

ADULT; ARTICLE; CARDIOVASCULAR MAGNETIC RESONANCE; CONTROLLED STUDY; FEMALE; HEART FUNCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE; HEART VENTRICLE ENDDIASTOLIC PRESSURE; HUMAN; MALE; MYOCARDIAL TRABECULATION; NORMAL HUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; VENTRICULAR NONCOMPACTION; YOUNG ADULT; ADOLESCENT; BLOOD; CARDIOMYOPATHY; DIASTOLE; ENZYME LINKED IMMUNOSORBENT ASSAY; FOLLOW UP; HEART ATRIUM; HEART CONTRACTION; HEART VENTRICLE; METHODOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; QUESTIONNAIRE; REFERENCE VALUE; RISK FACTOR;

ADOLESCENT; ADULT; CARDIOMYOPATHIES; DIASTOLE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW-UP STUDIES; HEART ATRIA; HEART VENTRICLES; HUMANS; MAGNETIC RESONANCE IMAGING, CINE; MALE; MYOCARDIAL CONTRACTION; MYOCARDIUM; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PROSPECTIVE STUDIES; PROTEIN PRECURSORS; QUESTIONNAIRES; REFERENCE VALUES; RISK FACTORS; YOUNG ADULT;

EID: 84909588138     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2014.07.025     Document Type: Article

References (30)

1. B.J. Maron, J.A. Towbin, G. Thiene, C. Antzelevitch, D. Corrado, D. Arnett, A.J. Moss, C.E. Seidman, and J.B. Young Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary working Groups; and Council on Epidemiology and Prevention Circulation 113 2006 1807 1816
2. P. Elliott, B. Andersson, E. Arbustini, Z. Bilinska, F. Cecchi, P. Charron, O. Dubourg, U. Kuhl, B. Maisch, W.J. McKenna, L. Monserrat, S. Pankuweit, C. Rapezzi, P. Seferovic, L. Tavazzi, and A. Keren Classification of the cardiomyopathies: a position statement from the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases Eur Heart J 29 2008 270 276
3. M.T. Boyd, J.B. Seward, A.J. Tajik, and W.D. Edwards Frequency and location of prominent left ventricular trabeculations at autopsy in 474 normal human hearts: implications for evaluation of mural thrombi by two-dimensional echocardiography J Am Coll Cardiol 9 1987 323 326
4. R. Jenni, E. Oechslin, J. Schneider, C. Attenhofer Jost, and P.A. Kaufmann Echocardiographic and pathoanatomical characteristics of isolated left ventricular non-compaction: a step towards classification as a distinct cardiomyopathy Heart 86 2001 666 671
5. C. Stollberger, J. Finsterer, and G. Blazek Left ventricular hypertrabeculation/noncompaction and association with additional cardiac abnormalities and neuromuscular disorders Am J Cardiol 90 2002 899 902
6. T.K. Chin, J.K. Perloff, R.G. Williams, K. Jue, and R. Mohrmann Isolated noncompaction of left ventricular myocardium. A study of eight cases Circulation 82 1990 507 513
7. S.E. Petersen, J.B. Selvanayagam, F. Wiesmann, M.D. Robson, J.M. Francis, R.H. Anderson, H. Watkins, and S. Neubauer Left ventricular non-compaction: insights from cardiovascular magnetic resonance imaging J Am Coll Cardiol 46 2005 101 105
8. G. Fazio, G. Novo, L. D'Angelo, C. Visconti, L. Sutera, E. Grassedonio, M. Galia, F. Ferrara, M. Midiri, and S. Novo Magnetic resonance in isolated noncompaction of the ventricular myocardium Int J Cardiol 140 2010 367 369
9. A.K. Abdulla, A. Frustaci, J.E. Martinez, R.A. Florio, J. Somerville, and E.G. Olsen Echocardiography and pathology of left ventricular "false tendons" Chest 98 1990 129 132
10. G. Tamborini, M. Pepi, F. Celeste, M. Muratori, F. Susini, A. Maltagliati, and F. Veglia Incidence and characteristics of left ventricular false tendons and trabeculations in the normal and pathologic heart by second harmonic echocardiography J Am Soc Echocardiogr 17 2004 367 374
11. R.C. Hendel, M.R. Patel, C.M. Kramer, M. Poon, R.C. Hendel, J.C. Carr, N.A. Gerstad, L.D. Gillam, J.M. Hodgson, R.J. Kim, C.M. Kramer, J.R. Lesser, E.T. Martin, J.V. Messer, R.F. Redberg, G.D. Rubin, J.S. Rumsfeld, A.J. Taylor, W.G. Weigold, P.K. Woodard, R.G. Brindis, R.C. Hendel, P.S. Douglas, E.D. Peterson, M.J. Wolk, J.M. Allen, and M.R. Patel ACCF/ACR/SCCT/SCMR/ASNC/NASCI/SCAI/SIR 2006 appropriateness criteria for cardiac computed tomography and cardiac magnetic resonance imaging: a report of the American College of Cardiology Foundation Quality Strategic Directions Committee Appropriateness Criteria Working Group, American College of Radiology, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, American Society of Nuclear Cardiology, North American Society for Cardiac Imaging, Society for Cardiovascular Angiography and Interventions, and Society of Interventional Radiology J Am Coll Cardiol 48 2006 1475 1497
12. H. Thiele, E. Nagel, I. Paetsch, B. Schnackenburg, A. Bornstedt, M. Kouwenhoven, A. Wahl, G. Schuler, and E. Fleck Functional cardiac MR imaging with steady-state free precession (SSFP) significantly improves endocardial border delineation without contrast agents J Magn Reson Imaging 14 2001 362 367
13. A. Jacquier, F. Thuny, B. Jop, R. Giorgi, F. Cohen, J.Y. Gaubert, V. Vidal, J.M. Bartoli, G. Habib, and G. Moulin Measurement of trabeculated left ventricular mass using cardiac magnetic resonance imaging in the diagnosis of left ventricular non-compaction Eur Heart J 31 2010 1098 1104
14. G. Captur, V. Muthurangu, C. Cook, A.S. Flett, R. Wilson, A. Barison, D.M. Sado, S. Anderson, W.J. McKenna, T.J. Mohun, P.M. Elliott, and J.C. Moon Quantification of left ventricular trabeculae using fractal analysis J Cardiovasc Magn Reson 15 2013 36
15. T. Papavassiliu, H.P. Kuhl, M. Schroder, T. Suselbeck, O. Bondarenko, C.K. Bohm, A. Beek, M.M. Hofman, and A.C. van Rossum Effect of endocardial trabeculae on left ventricular measurements and measurement reproducibility at cardiovascular MR imaging Radiology 236 2005 57 64
16. E. Larose, G. Proulx, P. Voisine, J. Rodes-Cabau, R. De Larochelliere, G. Rossignol, O.F. Bertrand, and J.P. Tremblay Percutaneous versus surgical delivery of autologous myoblasts after chronic myocardial infarction: an in vivo cardiovascular magnetic resonance study Catheter Cardiovasc Interv 75 2010 120 127
17. D.J. Pennell Ventricular volume and mass by CMR J Cardiovasc Magn Reson 4 2002 507 513
18. M. Sawyer, and M.J. Ratain Body surface area as a determinant of pharmacokinetics and drug dosing Invest New Drugs 19 2001 171 177
19. V. Palmieri, P.M. Okin, J.N. Bella, E. Gerdts, K. Wachtell, J. Gardin, V. Papademetriou, M.S. Nieminen, B. Dahlof, and R.B. Devereux Echocardiographic wall motion abnormalities in hypertensive patients with electrocardiographic left ventricular hypertrophy: the LIFE Study Hypertension 41 2003 75 82
20. L.E. Hudsmith, A.S. Cheng, D.J. Tyler, C. Shirodaria, J. Lee, S.E. Petersen, J.M. Francis, K. Clarke, M.D. Robson, and S. Neubauer Assessment of left atrial volumes at 1.5 Tesla and 3 Tesla using FLASH and SSFP cine imaging J Cardiovasc Magn Reson 9 2007 673 679
21. P.H. Luetmer, W.D. Edwards, J.B. Seward, and A.J. Tajik Incidence and distribution of left ventricular false tendons: an autopsy study of 483 normal human hearts J Am Coll Cardiol 8 1986 179 183
22. A.M. Maceira, J. Cosin-Sales, M. Roughton, S.K. Prasad, and D.J. Pennell Reference left atrial dimensions and volumes by steady state free precession cardiovascular magnetic resonance J Cardiovasc Magn Reson 12 2010 65
23. A.M. Maceira, S.K. Prasad, M. Khan, and D.J. Pennell Normalized left ventricular systolic and diastolic function by steady state free precession cardiovascular magnetic resonance J Cardiovasc Magn Reson 8 2006 417 426
24. N. Kawel, M. Nacif, A.E. Arai, A.S. Gomes, W.G. Hundley, W.C. Johnson, M.R. Prince, R.B. Stacey, J.A. Lima, and D.A. Bluemke Trabeculated (noncompacted) and compact myocardium in adults: the Multi-ethnic Study of Atherosclerosis Circ Cardiovasc Imaging 5 2012 357 366
25. C. Fernandez-Golfin, M. Pachon, C. Corros, A. Bustos, B. Cabeza, J. Ferreiros, L.P. de Isla, C. Macaya, and J. Zamorano Left ventricular trabeculae: quantification in different cardiac diseases and impact on left ventricular morphological and functional parameters assessed with cardiac magnetic resonance J Cardiovasc Med (Hagerstown) 10 2009 827 833
26. T.J. Wang, J.C. Evans, E.J. Benjamin, D. Levy, E.C. LeRoy, and R.S. Vasan Natural history of asymptomatic left ventricular systolic dysfunction in the community Circulation 108 2003 977 982
27. D.C. Peters, D.B. Ennis, and E.R. McVeigh High-resolution MRI of cardiac function with projection reconstruction and steady-state free precession Magn Reson Med 48 2002 82 88
28. G.I. Galasko, A. Lahiri, S.C. Barnes, P. Collinson, and R. Senior What is the normal range for N-terminal pro-brain natriuretic peptide? How well does this normal range screen for cardiovascular disease? Eur Heart J 26 2005 2269 2276
29. R.R. van Kimmenade, Y.M. Pinto, and J.L. Januzzi Jr. Importance and interpretation of intermediate (gray zone) amino-terminal pro-B-type natriuretic peptide concentrations Am J Cardiol 101 2008 39 42
30. V. Paget, L. Legedz, N. Gaudebout, N. Girerd, G. Bricca, H. Milon, M. Vincent, and P. Lantelme N-terminal pro-brain natriuretic peptide: a powerful predictor of mortality in hypertension Hypertension 57 2011 702 709